Daiichi Products Covered by National Health Insurance.Tokyo, Japan, Apr 5, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Some of Daiichi Pharmaceutical's Intrathecal intrathecal /in·tra·the·cal/ (-the´k'l) within a sheath; through the theca of the spinal cord into the subarachnoid space. Intrathecal Baclofen therapy products are now listed for national health insurance reimbursement. One of them is the SynchroMed infusion system that comprises of the SynchroMed EL pump and the InDura catheter. Intrathecal Gabalon (baclofen) and the SynchroMed system are used to treat severe spasticity spasticity /spas·tic·i·ty/ (spas-tis´i-te) the state of being spastic; see spastic (2). spas·tic·i·ty n. 1. A spastic state or condition. 2. Spastic paralysis. in patients if conventional treatments don't. The system involves a surgically implanted pump that automatically delivers baclofen directly to the spinal cord spinal cord, the part of the nervous system occupying the hollow interior (vertebral canal) of the series of vertebrae that form the spinal column, technically known as the vertebral column. when needed. Dosages delivered can be individually tailored are generally less than if taken orally. The SynchroMed system markedly reduces severe spasticity. SynchroMed infusion and Intrathecal Gabalong have been used to treat some 50,000 patients worldwide. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion